Page last updated: 2024-10-28

ifenprodil and Injury, Ischemia-Reperfusion

ifenprodil has been researched along with Injury, Ischemia-Reperfusion in 2 studies

ifenprodil: NMDA receptor antagonist

Research Excerpts

ExcerptRelevanceReference
" Six rats from each group were evaluated at 6 hours postocclusion for brain water content, an indicator of brain edema, and Evans blue dye extravasation for blood-brain barrier breakdown."7.69Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia. ( Başkaya, MK; Dempsey, RJ; Doğan, A; Donaldson, D; Rao, AM; Rao, VL; Rastl, J, 1997)
"Ifenprodil was encapsulated into liposomes by a remote loading method using pH gradient between internal and external water phases of liposomes, focusing on differences of its solubility in water depending on pH."5.51Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions. ( Agato, Y; Asai, T; Fukuta, T; Ishii, T; Kikuchi, T; Koide, H; Oku, N; Shimizu, K; Yanagida, Y, 2019)
" Six rats from each group were evaluated at 6 hours postocclusion for brain water content, an indicator of brain edema, and Evans blue dye extravasation for blood-brain barrier breakdown."3.69Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia. ( Başkaya, MK; Dempsey, RJ; Doğan, A; Donaldson, D; Rao, AM; Rao, VL; Rastl, J, 1997)
"Ifenprodil was encapsulated into liposomes by a remote loading method using pH gradient between internal and external water phases of liposomes, focusing on differences of its solubility in water depending on pH."1.51Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions. ( Agato, Y; Asai, T; Fukuta, T; Ishii, T; Kikuchi, T; Koide, H; Oku, N; Shimizu, K; Yanagida, Y, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, T1
Fukuta, T1
Agato, Y1
Yanagida, Y1
Ishii, T1
Koide, H1
Shimizu, K1
Oku, N1
Asai, T1
Doğan, A1
Rao, AM1
Başkaya, MK1
Rao, VL1
Rastl, J1
Donaldson, D1
Dempsey, RJ1

Other Studies

2 other studies available for ifenprodil and Injury, Ischemia-Reperfusion

ArticleYear
Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
    Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:12

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Disease Models, Animal; Hydrogen-Ion Concentrat

2019
Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
    Journal of neurosurgery, 1997, Volume: 87, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Blood-Brain Barrier; Body Temperature; Body W

1997